US · biotech · fertility · microbiome
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · Sept 2026 · $40M
Catalio Capital Management lead, General Catalyst, Alumni Ventures, Left Lane Capital, Labcorp Venture Fund, Rethink Impact, BBG Ventures, Muse Capital
Reported by TechCrunch and 1 other
Missing a round, or an investor who was in one? Tell us.